Nonoperative management of low-risk differentiated thyroid carcinoma

Current Opinion in Oncology

Volumn 27, Issue 1, 2015, Pages 15-20

  Ito, Yasuhiro ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Nonsurgical treatment; Observation; Papillary thyroid carcinoma; Papillary thyroid microcarcinoma; Prognosis

Indexed keywords

ALCOHOL; THYROTROPIN;

ALTERNATIVE MEDICINE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RISK; CANCER SURGERY; CONSERVATIVE TREATMENT; DIFFERENTIATED THYROID CANCER; HOSPITAL; HUMAN; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PAPILLARY THYROID MICROCARCINOMA; PREGNANCY; RADIOFREQUENCY ABLATION; REVIEW; CARCINOMA, PAPILLARY; DISEASE COURSE; THYROID NEOPLASMS; WATCHFUL WAITING;

CARCINOMA, PAPILLARY; DISEASE PROGRESSION; HUMANS; THYROID NEOPLASMS; WATCHFUL WAITING;

EID: 84916608387     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0000000000000143     Document Type: Review

References (29)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
2. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014; 140: 317-322.
3. Ito Y, Miyauchi A. A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrin Metab 2007; 3: 240-248.
4. Takebe K, Date M, Yamamoto Y, et al. Mass screening for thyroid cancer with ultrasonography [in Japanese]. KARKINOS 1994; 7: 309-317.
5. Ito Y, Uruno R, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13: 381-388.
6. Ito Y, Miyauchi A, Inoue H, et al. An observation trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 2010; 34: 28-35.
7. Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014; 24: 27-34.
8. Sugitani I, Koda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: Our treatment strategies and outcomes. World J Surg 2010; 34: 1222-1231.
9. Hotomi M, Sugitani I, Toda K, et al. A novel definition of extrathyroid invasion for patients with papillary thyroid carcinoma for predicting prognosis. World J Surg 2012; 36: 1230-1240.
10. Ito Y, Fukushima M, Kihara M, et al. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr J 2012; 59: 457-464.
11. Ito Y, Higashiyama T, Takamura Y, et al. Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests. World J Surg 2007; 31: 1872-1876.
12. Uruno T, Miyauchi A, Shimizu K, et al. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 2005; 29: 483-485.
13. Sugitani I, Fujimoto Y, Yamada K. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg 2014; 38: 673-678.
14. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97: 418-428.
15. Miyauchi A, Kudo T, Kihara M, et al. Relationship of biochemically persistent disease and thyroglobulin-doubling time to age at surgery in patients with papillary thyroid carcinoma. Endocr J 2013; 60: 415-421.
16. Miyauchi A, Kudo T, Miya A, et al. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 2011; 21: 707-716.
17. Cappelli C, Castellano M, Braga M, et al. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): A monoinstitutional experience. J Surg Oncol 2007; 95: 555-560.
18. Pelizzo MR, Boschin LM, Toniato A, et al. Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients. Eur J Sur Oncol 2006; 32: 1144-1148.
19. Neuhold N, Schulthels A, Hermann M, et al. Incidental papillary microcarcinoma of the thyroid-further evidence of a very low malignant potential: A retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol 2011; 18: 3430-3436.
20. Hay ID, Hutchinson ME, Gonzalez-losada T, et al. Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period. Surgery 2008; 144: 980-987.
21. Lang BHH, Wong KP. Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma. Ann Surg Oncol 2011; 11: 3559-3565.
22. Lee X, Gao M, Ji Y, et al. Analysis of differential BRAFV600E mutational status in high aggressive papillary thyroid microcarcinoma. Ann Surg Oncol 2009; 16: 240-245.
23. Rossi ED, Martini M, Capodimonti S, et al. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid carcinoma. Cancer Cytopathol 2013; 121: 291-297.
24. Ito Y, Yoshida H, Maruo R, et al. BRAF mutation in papillary thyroid carcinoma in a Japanese population: Its lack of correlation with high-risk clinicopathological features and disease-free survival patients. Endocr J 2009; 56: 89-97.
25. Ito Y, Yoshida H, Kihara M, et al. BRAF (V600E) mutation analysis in papillary thyroid carcinoma: Is it useful for all patients? World J Surg 2014; 38: 679-687.
26. Lim CY, Yun JS, Lee J, et al. Percutaneous ethanol injection for locally recurrent papillary thyroid carcinoma. Thyroid 2007; 17: 347-350.
27. Baek JH, Kim YS, Sung JY, et al. Locoregional control of metastatic well differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol 2011; 197: W331-W336.
28. Shindo H, Amino N, Ito Y, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 2014; 24: 840-844.
29. Takami H, Ito Y, Okamoto T, Yoshida A. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 2011; 35: 111-121.